NeuroVive Pharmaceutical AB of Sweden has elected Anna Malm Bernsten, formerly chief marketing officer at GE Healthcare Life Sciences, to its board of directors. Ms Bernsten holds an MSc in chemical engineering from the Royal Institute of Technology in Stockholm and has substantial marketing experience. Concurrently, the company elected Boel Flodgren, an academic, to the board. Ms Flodgren is a senior professor of business law at the School of Economics and Management at Lund University. She was previously president of the university for ten years.
NeuroVive, a mitochondrial medicine company, announced the appointments on 18 March 2013.
Copyright 2013 Evernow Publishing Ltd.